Team Member

Dr Angela George

Medical Director

Dr Angela George is a Consultant Medical Oncologist and Consultant in Oncogenetics at the Royal Marsden Hospital.  She specialises in the systemic treatment of gynaecological cancers and has a particular focus on the use of genomic information in treatment.  She is also Clinical Director of Genomics at the Royal Marsden, overseeing the Centre for Molecular Pathology, and undertakes testing for inherited cancer syndromes in her Oncogenetics practice.

Dr George trained initially in New Zealand in Medical Oncology, before moving to the Royal Marsden and undertaking additional training in Oncogenetics at the Institute of Cancer Research, where she was awarded the Chairman’s Prize for her Thesis in Ovarian Cancer Genetics.  She led the implementation of the Mainstreaming Cancer Genetics programme, which involved incorporating genetic testing into the routine care of patients with ovarian, breast and pancreatic cancers.  These programmes have now been adopted across the UK and Dr George has helped set these programmes up across the world, expanding into multiple tumour types and revolutionising the use of routine genomic information in cancer management.  She currently runs several programmes investigating the role of molecular profiling in cancer management and holds a number of grants for research into molecular profiling, genomic screening, and the early detection of cancer in individuals with an inherited predisposition to cancer.

Dr George is involved in multiple national and international groups, including the National Cancer Research Institute Gynaecological Cancers Group, the Precision Medicine working group for the European Society of Medical Oncology and the British Society of Genetic Medicine.  She was the Cancer Clinical Lead for the North Thames Genomic Medicine Service and co-chairs the molecular tumour board.  She sits on the Clinical Advisory Group for the NHS England Genomics Unit and the NHSE Genomics Clinical Reference Group (CRG) and is on the UK Cancer Genetics Group steering committee.

Dr George has authored multiple peer-reviewed publications and book chapters, and undertakes a variety of clinical and translational research, particularly in cancer genomics and targeted treatments.  She is the principal investigator at The Royal Marsden for multiple international trials and chief investigator for a number of international trials.